China
Healthcare AI in China: Trends, Innovations, and Market Insights (2025)
China is rapidly emerging as a global leader in healthcare AI, driven by government initiatives, technological innovation, and widespread adoption across hospitals and patient care.
By 2030, authorities plan to integrate AI extensively across the health system, from medical imaging and clinical decision support to patient-facing services.
This pillar page provides a comprehensive overview of the key players, technologies, trends, and regulatory landscape shaping healthcare AI in China.
Major Players in China’s Healthcare AI Ecosystem
Ping An Good Doctor
Ping An is expanding its AI services nationwide, including home-based senior care models and its AI-powered digital twin service, Ping An Xin Yi, enabling real-time health monitoring and remote consultations.
Ant Group / AQ Health
Ant Group’s AI healthcare app, AQ (known as Ant A-Fu in China), serves over 140 million users, including in tier-3 cities and below. Features include AI companions for daily health guidance, health Q&A, and detection of fraudulent health advertising.
Fangzhou & DeepSeek
Fangzhou integrates AI into chronic disease management platforms, while DeepSeek develops training frameworks for next-generation AI in healthcare. Human–AI collaboration studies with Sun Yat-sen University highlight the potential to improve adoption and clinical outcomes.
BGI Genomics
BGI Genomics is pioneering AI-driven genomics research, with China on track to build its first nationwide gene database by 2049. BGI’s initiatives include collaborations across Asia, contributing to personalized healthcare and precision medicine.
Key AI Applications in Healthcare
Diagnostics & Imaging
AI models, including the ‘AI paediatrician’, are matching expert clinical recommendations for complex cases.
Tools such as AI-based ovarian cancer detection are improving diagnostic accuracy in routine and primary care.
Clinical Decision Support
AI platforms provide rare disease consultations and assist clinicians with data-driven decision-making.
Digital twin services allow real-time monitoring and preventive interventions.
Patient-Facing Services & Home Care
AI supports senior care models, remote consultations, and chronic disease monitoring.
Companion apps help patients maintain daily health routines and preventive care habits.
Government & Regulatory Landscape
China plans to develop over 50 national and industrial AI standards by 2026.
AI adoption is encouraged across medical imaging, diagnostics, and patient-facing services.
Regulatory guidance tools from the Digital Medicine Society help developers navigate complex healthcare regulations, supporting safe deployment of AI products.
Research, Collaboration, and Innovation
Multi-stakeholder collaborations are accelerating healthcare AI integration.
Universities and hospitals partner with companies to conduct clinical research and validate AI models.
BGI Genomics, Fangzhou, and other institutions are leading research into genomics, human–AI collaboration, and precision medicine.
Market Insights & Trends
AI adoption is expanding into lower-tier cities, broadening access to digital healthcare.
Pharma partnerships and integrated digital ecosystems are shaping patient care.
Consumer uptake of AI health apps is growing rapidly, demonstrating the potential for widespread adoption.
Chinese healthcare AI companies are expanding internationally, including the Middle East.
Partnerships in countries like Saudi Arabia leverage expertise in AI diagnostics, telemedicine, and chronic disease management, supporting local digital health initiatives and joint ventures.
Key Challenges
Privacy, data security, and patient consent remain critical concerns.
Regulatory compliance varies across regions, requiring careful navigation by innovators.
Balancing automation with human oversight is essential to maintain clinical trust.
Conclusion / Future Outlook
China is on track to become a leader in AI-driven healthcare, transforming patient access, preventive care, and chronic disease management by 2030.
For global healthcare organisations, startups, and investors, understanding these trends and the capabilities of Chinese AI innovators is increasingly important—these companies are not only reshaping healthcare in China but also offer significant opportunities for collaboration, partnership, and technology adoption abroad.
HealthTechAsia will continue to track and analyse this evolving landscape, providing actionable insights for the international healthtech community.